The Impact of Air Pollution on Neurodegenerative Diseases : Therapeutic Drug Monitoring

Secondary Logo

Journal Logo

Review Article

The Impact of Air Pollution on Neurodegenerative Diseases

Wang, Jian*,†; Ma, Tengfei*,†; Ma, Ding*,†; Li, Huimin*; Hua, Li MM*; He, Qing PhD; Deng, Xiaobei PhD*

Author Information
Therapeutic Drug Monitoring 43(1):p 69-78, February 2021. | DOI: 10.1097/FTD.0000000000000818

Abstract

Background: 

With the development of industrialization in human society, ambient pollutants are becoming more harmful to human health. Epidemiological and toxicological studies indicate that a close relationship exists between particulate matter with a diameter ≤2.5 µm (PM2.5) and neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD). To further confirm the relationship, we focus on possible relevant mechanisms of oxidative stress and neuroinflammation underlying the association between PM2.5 and neurodegenerative diseases in the review.

Methods: 

A literature search was performed on the studies about PM2.5 and neurodegenerative diseases via PubMed. A total of 113 articles published were selected, and 31 studies were included.

Results: 

PM2.5 can enter the central nervous system through 2 main pathways, the blood–brain barrier and olfactory neurons. The inflammatory response and oxidative stress are 2 primary mechanisms via which PM2.5 leads to toxicity in the brain. PM2.5 abnormally activates microglia, inducing the neuroinflammatory process. Inflammatory markers such as IL-1β play an essential role in neurodegenerative diseases such as AD and PD. Moreover, the association between lipid mechanism disorders related to PM2.5 and neurodegenerative diseases has been gaining momentum.

Conclusions: 

In conclusion, PM2.5 could significantly increase the risk of neurological disorders, such as AD and PD. Furthermore, any policy aimed at reducing air-polluting emissions and increasing air quality would be protective in human beings.

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid